BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34999436)

  • 1. Rapid and non-invasive discrimination of acute leukemia bone marrow supernatants by Raman spectroscopy and multivariate statistical analysis.
    Liang H; Cheng X; Dong S; Wang H; Liu E; Ru Y; Li Y; Kong X; Gao Y
    J Pharm Biomed Anal; 2022 Feb; 210():114560. PubMed ID: 34999436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting prognosis in acute myeloid leukemia patients by surface-enhanced Raman spectroscopy.
    Chen S; Wang C; Zhu R; Zhu S; Zhang G
    Nanomedicine (Lond); 2021 Sep; 16(21):1873-1885. PubMed ID: 34269596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of serum Raman spectroscopy in rapid and early discrimination of aplastic anemia and myelodysplastic syndrome.
    Liang H; Kong X; Ren Y; Wang H; Liu E; Sun F; Zhu G; Zhang Q; Zhou Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Dec; 302():123008. PubMed ID: 37328404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of acute myeloid leukemia by infrared difference spectrum of peripheral blood.
    Xie L; Wang J; Wang N; Zhu J; Yin Q; Guo R; Duan J; Wang S; Hao C; Shen X
    J Pharm Biomed Anal; 2023 Sep; 233():115454. PubMed ID: 37178631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Label-Free Identification of AML1-ETO Positive Acute Myeloid Leukemia Using Single-Cell Raman Spectroscopy.
    Wang Y; Wang Y; Chen X; Zhu M; Xu Y; Wu Y; Gao S; Zhang M; Su L; Han W; Chi M
    Appl Spectrosc; 2024 May; ():37028241254403. PubMed ID: 38772561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype discrimination of acute myeloid leukemia based on plasma SERS technique.
    Ye M; Chen Y; Wang Y; Xiao L; Lin Q; Lin H; Duan Z; Feng S; Cao Y; Zhang J; Li J; Hu J
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Apr; 271():120865. PubMed ID: 35063821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation and prognostic stratification of acute myeloid leukemia by serum-based spectroscopy coupling with metabolic fingerprints.
    Duan Z; Chen Y; Ye M; Xiao L; Chen Y; Cao Y; Peng Y; Zhang J; Zhang Y; Yang T; Liu W; Feng S; Hu J
    FASEB J; 2022 Jul; 36(7):e22416. PubMed ID: 35713583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free imaging and identification of typical cells of acute myeloid leukaemia and myelodysplastic syndrome by Raman microspectroscopy.
    Vanna R; Ronchi P; Lenferink AT; Tresoldi C; Morasso C; Mehn D; Bedoni M; Picciolini S; Terstappen LW; Ciceri F; Otto C; Gramatica F
    Analyst; 2015 Feb; 140(4):1054-64. PubMed ID: 25568900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8].
    Wang JH; Yao B; Guo M; Qiao JH; Sun QY; Hu KX; Li BX; Yu CL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):655-61. PubMed ID: 27342486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raman spectroscopy differ leukemic cells from their healthy counterparts and screen biomarkers in acute leukemia.
    Cheng X; Liang H; Li Q; Wang J; Liu J; Zhang Y; Ru Y; Zhou Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121558. PubMed ID: 35843058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of acute myeloid leukemia and system Coulter VCS.
    Bruno A; Del Poeta G; Venditti A; Stasi R; Adorno G; Aronica G; Suppo G; Di Rienzo AM; Iazzoni R; Tribalto M
    Haematologica; 1994; 79(5):420-8. PubMed ID: 7843628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the Heterogeneity of Serum Metabolism in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia by Raman Spectroscopy.
    Liang H; Kong X; Wang H; Ren Y; Liu E; Sun F; Qi J; Zhang Q; Zhou Y
    ACS Omega; 2022 Dec; 7(50):47056-47069. PubMed ID: 36570283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia.
    Liang H; Kong X; Cao Z; Wang H; Liu E; Sun F; Qi J; Zhang Q; Zhou Y
    Front Immunol; 2023; 14():1194353. PubMed ID: 37266435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructure and Raman Spectral Characteristics of Two Kinds of Acute Myeloid Leukemia Cells].
    Liang HY; Cheng XL; Dong SX; Zhao SX; Wang Y; Ru YX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):1-7. PubMed ID: 29397810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raman spectroscopy-based biomarker screening by studying the fingerprint characteristics of chronic lymphocytic leukemia and diffuse large B-cell lymphoma.
    Bai Y; Yu Z; Yi S; Yan Y; Huang Z; Qiu L
    J Pharm Biomed Anal; 2020 Oct; 190():113514. PubMed ID: 32827998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
    da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
    Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression pattern of CD56 (N-CAM) in human bone marrow biopsies infiltrated by acute leukemia.
    Khanlari B; Buser A; Lugli A; Tichelli A; Dirnhofer S
    Leuk Lymphoma; 2003 Dec; 44(12):2055-9. PubMed ID: 14959847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
    Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
    Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.